A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile

Lídia Perea, Elisabet Cantó, Guillermo Suarez-Cuartin, Stefano Aliberti, James D. Chalmers, Oriol Sibila, Silvia Vidal (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    19 Citations (Scopus)


    Background: Clinical heterogeneity in bronchiectasis remains a challenge for improving the appropriate targeting of therapies and patient management. Antimicrobial peptides (AMPs) have been linked to disease severity and phenotype.

    Research Question: Can we identify clusters of patients based on the levels of AMPs, airway inflammation, tissue remodeling, and tissue damage to establish their relationship with disease severity and clinical outcomes?

    Study Design and Methods: A prospective cohort of 128 stable patients with bronchiectasis were recruited across three centers in three different countries (Spain, Scotland, and Italy). A two-step cluster strategy was used to stratify patients according to levels of lactoferrin, lysozyme, LL-37, and secretory leukocyte protease inhibitor in sputum. Measurements of inflammation (IL-8, tumor growth factor β, and IL-6), tissue remodeling and damage (glycosaminoglycan, matrix metallopeptidase 9, neutrophil elastase, and total and bacterial DNA), and neutrophil chemotaxis were assessed.

    Results: Three clusters of patients were defined according to distinct airway profiles of AMPs. They represented groups of patients with gradually distinct airway infection and disease severity. Each cluster was associated with an airway profile of inflammation, tissue remodeling, and tissue damage. The relationships between soluble mediators also were distinct between clusters. This analysis allowed the identification of the cluster with the most deregulated local innate immune response. During follow-up, each cluster showed different risk of three or more exacerbations occurring (P = .03) and different times to first exacerbations (P = .03).

    Interpretation: Bronchiectasis patients can be stratified in different clusters according to profiles of airway AMPs, inflammation, tissue remodeling, and tissue damage. The combination of these immunologic variables shows a relationship with disease severity and future risk of exacerbations.

    Original languageEnglish
    Pages (from-to)1758-1767
    Number of pages10
    Issue number5
    Early online date18 Nov 2020
    Publication statusPublished - 1 May 2021


    • Aged
    • Biomarkers/blood
    • Bronchiectasis/immunology
    • Cluster Analysis
    • Female
    • Humans
    • Inflammation/immunology
    • Italy
    • Male
    • Prospective Studies
    • Scotland
    • Severity of Illness Index
    • Spain
    • Sputum/chemistry
    • bronchiectasis
    • exacerbations
    • airway immunity
    • cluster analysis

    ASJC Scopus subject areas

    • Critical Care and Intensive Care Medicine
    • Cardiology and Cardiovascular Medicine
    • Pulmonary and Respiratory Medicine


    Dive into the research topics of 'A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile'. Together they form a unique fingerprint.

    Cite this